125 related articles for article (PubMed ID: 17664955)
1. Subclinical carotid atherosclerosis in a patient with systemic lupus erythematosus.
Alpert D; Davis A; Erkan D; Roman MJ; Salmon JE
Nat Clin Pract Rheumatol; 2007 Aug; 3(8):473-8; quiz, 2nd following 478. PubMed ID: 17664955
[TBL] [Abstract][Full Text] [Related]
2. Carotid atherosclerotic alterations in systemic lupus erythematosus patients treated at a Brazilian university setting.
Telles RW; Lanna CC; Ferreira GA; Souza AJ; Navarro TP; Ribeiro AL
Lupus; 2008 Feb; 17(2):105-13. PubMed ID: 18250133
[TBL] [Abstract][Full Text] [Related]
3. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis.
Sharma SK; Rathi M; Sahoo S; Prakash M; Dhir V; Singh S
Lupus; 2016 Apr; 25(5):525-31. PubMed ID: 26678442
[TBL] [Abstract][Full Text] [Related]
4. Subclinical atherosclerosis in systemic lupus erythematosus (SLE): the relative contribution of classic risk factors and the lupus phenotype.
Ahmad Y; Shelmerdine J; Bodill H; Lunt M; Pattrick MG; Teh LS; Bernstein RM; Walker MG; Bruce IN
Rheumatology (Oxford); 2007 Jun; 46(6):983-8. PubMed ID: 17384179
[TBL] [Abstract][Full Text] [Related]
5. Decreased circulating endothelial progenitor cells as an early risk factor of subclinical atherosclerosis in systemic lupus erythematosus.
Castejon R; Jimenez-Ortiz C; Valero-Gonzalez S; Rosado S; Mellor S; Yebra-Bango M
Rheumatology (Oxford); 2014 Apr; 53(4):631-8. PubMed ID: 24273021
[TBL] [Abstract][Full Text] [Related]
6. Body mass index and glucocorticoid dose contribute to subclinical atherosclerosis in Korean patients with systemic lupus erythematosus: A prospective 4 year follow-up study.
Jung JY; Kim HA; Lee HY; Suh CH
Int J Rheum Dis; 2019 Aug; 22(8):1410-1418. PubMed ID: 31050219
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus.
Roman MJ; Shanker BA; Davis A; Lockshin MD; Sammaritano L; Simantov R; Crow MK; Schwartz JE; Paget SA; Devereux RB; Salmon JE
N Engl J Med; 2003 Dec; 349(25):2399-406. PubMed ID: 14681505
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of risk factors that contribute to high prevalence of premature atherosclerosis in Chinese premenopausal systemic lupus erythematosus patients.
Zhang CY; Lu LJ; Li FH; Li HL; Gu YY; Chen SL; Bao CD
J Clin Rheumatol; 2009 Apr; 15(3):111-6. PubMed ID: 19300290
[TBL] [Abstract][Full Text] [Related]
9. Coronary artery disease in patients with systemic lupus erythematosus.
Galindo M; Chung L; Crockett SD; Chakravarty EF
Nat Clin Pract Rheumatol; 2005 Nov; 1(1):55-9; quiz 60. PubMed ID: 16932628
[TBL] [Abstract][Full Text] [Related]
10. Disease trends over time and CD4
Baragetti A; Ramirez GA; Magnoni M; Garlaschelli K; Grigore L; Berteotti M; Scotti I; Bozzolo E; Berti A; Camici PG; Catapano AL; Manfredi AA; Ammirati E; Norata GD
Nutr Metab Cardiovasc Dis; 2018 Jan; 28(1):53-63. PubMed ID: 29150407
[TBL] [Abstract][Full Text] [Related]
11. Rate and determinants of progression of atherosclerosis in systemic lupus erythematosus.
Roman MJ; Crow MK; Lockshin MD; Devereux RB; Paget SA; Sammaritano L; Levine DM; Davis A; Salmon JE
Arthritis Rheum; 2007 Oct; 56(10):3412-9. PubMed ID: 17907140
[TBL] [Abstract][Full Text] [Related]
12. Subclinical atherosclerosis in rheumatoid arthritis and systemic lupus erythematosus.
Salmon JE; Roman MJ
Am J Med; 2008 Oct; 121(10 Suppl 1):S3-8. PubMed ID: 18926167
[TBL] [Abstract][Full Text] [Related]
13. Panenteritis as an Initial Presentation of Systemic Lupus Erythematosus.
Lee HA; Shim HG; Seo YH; Choi SJ; Lee BJ; Lee YH; Ji JD; Kim JH; Song GG
Korean J Gastroenterol; 2016 Feb; 67(2):107-11. PubMed ID: 26907488
[TBL] [Abstract][Full Text] [Related]
14. Acquired enophthalmos with systemic lupus erythematosus.
Park KR; Seo MR; Ryu HJ; Chi MJ; Baek HJ; Choi HJ
Lupus; 2016 Jan; 25(1):88-92. PubMed ID: 26306741
[TBL] [Abstract][Full Text] [Related]
15. [Soluble CD40 ligand in systemic lupus erythematosus: link with atherosclerotic vascular affection].
Popkova TV; Panafidina TA; Aleksandrova EN; Novikova DS; Novikov AA; Alekberova ZS; Mach ES; Nasonov EL
Ter Arkh; 2008; 80(5):37-41. PubMed ID: 18590112
[TBL] [Abstract][Full Text] [Related]
16. Subclinical atherosclerosis in Systemic Lupus Erythematosus: Comparable risk with Diabetes Mellitus and Rheumatoid Arthritis.
Tektonidou MG; Kravvariti E; Konstantonis G; Tentolouris N; Sfikakis PP; Protogerou A
Autoimmun Rev; 2017 Mar; 16(3):308-312. PubMed ID: 28147263
[TBL] [Abstract][Full Text] [Related]
17. Atherosclerotic plaque in carotid arteries in systemic lupus erythematosus: frequency and associated risk factors.
Souza AW; Hatta FS; Miranda F; Sato EI
Sao Paulo Med J; 2005 May; 123(3):137-42. PubMed ID: 16021278
[TBL] [Abstract][Full Text] [Related]
18. [Interleukin-18 in systemic lupus erythematosus: link with clinical symptoms and vascular atherosclerosis].
Panafidina TA; Popkova TV; Alekberova ZS; Mach ES; Aleksandrova EN; Nasonov EL
Ter Arkh; 2008; 80(5):41-6. PubMed ID: 18590113
[TBL] [Abstract][Full Text] [Related]
19. 'Not only...but also': factors that contribute to accelerated atherosclerosis and premature coronary heart disease in systemic lupus erythematosus.
Bruce IN
Rheumatology (Oxford); 2005 Dec; 44(12):1492-502. PubMed ID: 16234277
[TBL] [Abstract][Full Text] [Related]
20. Subclinical atherosclerosis in systemic lupus erythematosus patients and its relationship to disease activity and damage indices.
Fadda S; Nassar H; Gamal SM; Al-azizi H
Z Rheumatol; 2015 Aug; 74(6):529-32. PubMed ID: 25098691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
